Answer
Some of the most commonly reported gastrointestinal adverse effects of cabozantinib are diarrhoea, nausea/vomiting, decreased appetite, and stomatitis/oral pain.
Sources for this answer
- COMETRIQ 20 & 80 mg hard capsulesIpsen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 15Document updated
Sources checked